0001610717-23-000106.txt : 20230608 0001610717-23-000106.hdr.sgml : 20230608 20230608175721 ACCESSION NUMBER: 0001610717-23-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221125 FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Friedman Jonathan I CENTRAL INDEX KEY: 0001415556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40902 FILM NUMBER: 231003204 MAIL ADDRESS: STREET 1: DENTSPLY SIRONA INC. STREET 2: 30-30 47TH AVENUE, SUITE 500 CITY: LONG ISLAND CITY STATE: NY ZIP: 11101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paragon 28, Inc. CENTRAL INDEX KEY: 0001531978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 273170186 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 14445 GRASSLANDS DRIVE CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 720-912-1332 MAIL ADDRESS: STREET 1: 14445 GRASSLANDS DRIVE CITY: ENGLEWOOD STATE: CO ZIP: 80112 4 1 form4.xml X0407 4 2022-11-25 true 0001531978 Paragon 28, Inc. FNA 0001415556 Friedman Jonathan I C/O PARAGON 28, INC. 14445 GRASSLANDS DRIVE ENGLEWOOD CO 80112 true See Remarks false Common Stock 2022-11-25 4 M 0 12500 13.706 A 64554 D Common Stock 2022-11-25 4 S 0 12500 20.3451 D 52054 D Common Stock 2022-12-01 4 M 0 2500 13.706 A 54554 D Common Stock 2022-12-01 4 S 0 2500 20.5 D 52054 D Stock Option (Right to Buy) 13.706 2022-11-25 4 M 0 12500 0 D 2031-08-16 Common Stock 12500 107500 D Stock Option (Right to Buy) 13.706 2022-12-01 4 M 0 2500 0 D 2031-08-16 Common Stock 2500 105000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.05 to $20.40, inclusive. The reporting person undertakes to provide to Paragon 28, Inc., any security holder of Paragon 28, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). 25% of the shares subject to the option vest annually measured from August 16, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Former general counsel. The reporting person ceased to be an officer of the Issuer as of April 9, 2023. /s/ Stephen Deitsch, as Attorney-in-Fact for Jonathan Friedman 2023-06-08